Covaxin to no longer carry ‘clinical trial mode’ label,

Bharat Biotech’s COVID-19 vaccine, Covaxin, will no longer have to carry the ‘clinical trial mode’ label. Serum Institute of India’s Covishield already has this status. Earlier, Covaxin was granted restricted emergency use authorisation before the completion of trials. The government-backed vaccine has been developed by Bharat Biotech, a 24-year-old vaccine maker, which 16 vaccines to its name […]

Continue Reading